Nalaganje...
Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects
Bcr-Abl acquires its transforming abilitythro ugh its upregulated Abl tyrosine kinase activity. Bcr is a phosphoprotein with a novel serine/threonine kinase activitye ncoded by its first exon. In chronic myelogenous leukemia (CML) cells, Bcr-Abl phosphorylates Bcr on tyrosine residues reducing its k...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2007
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2585769/ https://ncbi.nlm.nih.gov/pubmed/17934518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.onc.1210851 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|